Healthcare


 Monash IVF Group ASX 300 Updates Earnings Outlook as Sector Activity Softens

Monash IVF Group ASX 300 Updates Earnings Outlook as Sector Activity Softens

June 12, 2026 11:07 AM AEST| By Sam

Monash IVF Group updated its earnings outlook amid softer fertility sector activity while expanding market share, strengthening international operations and continuing clinical network development initiatives.

 Why OncoSil’s Quiet Update Could Signal a Defining Period Ahead

Why OncoSil’s Quiet Update Could Signal a Defining Period Ahead

June 12, 2026 11:05 AM AEST| By Sam

OncoSil enters a crucial phase as regulatory progress, clinical data, manufacturing expansion, and commercial adoption become the central themes shaping its future.

 Why ASX Healthcare Stocks Are Back Under the Microscope

Why ASX Healthcare Stocks Are Back Under the Microscope

June 11, 2026 09:46 PM AEST| By Sam

Healthcare stocks are being reassessed through the diagnostics and devices theme, with readers focusing on business quality, product adoption, operational discipline and the signals influencing sector sentiment.

Sponsored
https://kalkineauuknzusca.blob.core.windows.net/kalkineallsubdata/au/gallery/xlarge/Cancerdig_06_12_2026_05_07_51_888693.jpg

Kalkine Stock Analysis: Are Investors Reassessing Alterity Therapeutics' Clinical Pipeline?

June 12, 2026 05:06 AM AEST| By Aditi Sarkar

Alterity Therapeutics Ltd (ASX: ATH) attracted market attention on 12 June 2026 after its shares climbed 14.61% to AUD 0.51. The stock opened at AUD 0.46 and traded within a range of AUD 0.45 to AUD 0.52 during the session, reflecting increased investor activity …

 Healthcare Stocks Nobody Can Ignore as Valuation Repair Gains Pace

Healthcare Stocks Nobody Can Ignore as Valuation Repair Gains Pace

June 11, 2026 09:45 PM AEST| By Sam

Healthcare stocks are being reassessed through valuation repair, with markets focusing on revenue quality, product adoption, margins and execution as companies work to strengthen confidence across the Australian healthcare sector.

 From Trial Hope to Revenue Proof: Why Healthcare Stocks Face a Bigger Test

From Trial Hope to Revenue Proof: Why Healthcare Stocks Face a Bigger Test

June 11, 2026 09:43 PM AEST| By Sam

Australian healthcare stocks are entering a more evidence-driven phase, with attention shifting towards commercial proof, revenue quality, product adoption and operational execution across leading healthcare businesses.

 Why Are These Healthcare Stocks Capturing Market Attention?

Why Are These Healthcare Stocks Capturing Market Attention?

June 11, 2026 03:00 PM AEST| By Sam

Seven healthcare companies spanning biotechnology, diagnostics, hospitals, medical devices, and healthcare software continue drawing attention across Australia's healthcare sector and major market indices.

Sponsored
https://kalkineauuknzusca.blob.core.windows.net/kalkineallsubdata/au/gallery/xlarge/biotechnologyMNMN_06_12_2026_05_06_43_135429.jpg

Kalkine Healthcare Focus: Why Is Tetratherix (ASX:TTX) Among Today's Top Healthcare Gainers?

June 12, 2026 05:05 AM AEST| By Aditi Sarkar

Tetratherix Ltd (ASX:TTX) attracted investor attention on 12 June 2026 after its shares climbed 13.71% to AUD 5.97. The stock opened at AUD 5.40 and reached an intraday high of AUD 6.00 before trading near those levels during the session.

 Which Healthcare Leader Commands More Attention Now?

Which Healthcare Leader Commands More Attention Now?

June 11, 2026 03:00 PM AEST| By Sam

Leading ASX healthcare companies continue to attract attention through biotechnology, diagnostics, hearing technology and respiratory care, supported by healthcare demand and operational quality.

 Bell Potter Backs Cogstate as Healthcare Tech Growth Gains Momentum

Bell Potter Backs Cogstate as Healthcare Tech Growth Gains Momentum

June 11, 2026 02:22 PM AEST| By Sam

Cogstate continues building momentum through healthcare technology innovation, strategic partnerships and expanding opportunities across clinical research markets.

 Are ASX Healthcare Stocks Rebuilding Strength?

Are ASX Healthcare Stocks Rebuilding Strength?

June 11, 2026 02:22 PM AEST| By Sam

ASX healthcare stocks are being reviewed through operational resets, product adoption, hospital activity, diagnostics demand and medical software signals.

Sponsored
https://kalkineauuknzusca.blob.core.windows.net/kalkineallsubdata/au/gallery/xlarge/healthcareprovider_06_12_2026_04_20_53_183524.jpg

Kalkine ASX Update: What Is Supporting Momentum in LTR Pharma (ASX:LTP)?

June 12, 2026 04:19 AM AEST| By Aditi Sarkar

LTR Pharma Ltd (ASX:LTP) attracted investor attention on 12 June 2026 after its shares climbed 16.00% to AUD 0.58. The stock opened at AUD 0.52 and traded within a range of AUD 0.50 to AUD 0.61 during the session, reflecting increased buying activity throughout …

 Canberra Drone Maker’s ASX Arrival Sparks Fresh Defence Focus

Canberra Drone Maker’s ASX Arrival Sparks Fresh Defence Focus

June 11, 2026 09:29 AM AEST| By Sam

Boresight has entered the ASX as a defence technology company specialising in aerial target drones, with global military customers, expanding manufacturing operations, and a growing role in modern defence training solutions.

 ASX Healthcare Innovators 2026: Australia's Global Champions

ASX Healthcare Innovators 2026: Australia's Global Champions

June 10, 2026 09:55 PM AEST| By Sam

Australia's healthcare sector has produced globally recognised leaders through innovation, specialised expertise and international expansion, with CSL, Cochlear, ResMed and Pro Medicus showcasing the country's ability to compete successfully on the w...

 The Market’s Quiet Achiever: Why Healthcare Keeps Winning

The Market’s Quiet Achiever: Why Healthcare Keeps Winning

June 10, 2026 09:53 PM AEST| By Vivek Singh

Healthcare combines defensive demand with structural growth from ageing populations and medical innovation. From global healthcare leaders to emerging technology specialists, the sector offers resilience and long-term relevance.

Sponsored
https://kalkineauuknzusca.blob.core.windows.net/kalkineallsubdata/au/gallery/xlarge/Vaccinenmn_06_12_2026_04_19_44_699434.jpg

Kalkine ASX Update: What Is Supporting Momentum in Neuroscientific Biopharmaceuticals (ASX:NSB)?

June 12, 2026 04:17 AM AEST| By Aditi Sarkar

Neuroscientific Biopharmaceuticals Ltd (ASX:NSB) attracted investor attention on 12 June 2026 after its shares climbed 16.67% to AUD 0.070. The stock opened at AUD 0.064 and traded within a range of AUD 0.064 to AUD 0.077 during the session, reflecting increased activity across the …

 Healthcare's Hidden Comeback Story Few Saw Coming

Healthcare's Hidden Comeback Story Few Saw Coming

June 10, 2026 09:51 PM AEST| By Sam

Australia's leading healthcare companies faced significant pressure from costs, currency movements and market concerns, yet strong industry fundamentals, demographic trends and enduring healthcare demand continue to support the sector's long-term out...

 Kalkine ASX News: Cogstate Ltd (ASX:CGS) Pushes Higher as Healthcare Tech Momentum Build

Kalkine ASX News: Cogstate Ltd (ASX:CGS) Pushes Higher as Healthcare Tech Momentum Build

June 10, 2026 09:41 PM AEST| By Sam

Highlights,Cogstate attracted strong investor interest as healthcare technology stocks gained momentum on the ASX.,Elevated trading activity highlighted broad market participation in the stock.,The company operates in digital cognitive assessment, su...

 Singular Health (ASX:SHG) Expands U.S. Reach as 3DICOM Adoption Accelerates

Singular Health (ASX:SHG) Expands U.S. Reach as 3DICOM Adoption Accelerates

June 10, 2026 04:18 PM AEST| By Aditi Sarkar

Highlights,Singular Health Group secured a US$500,000 payment after deploying an additional 500 3DICOM MD® licences across the Provider Network Solutions healthcare network.,The company expanded adoption of 3DICOM MD® within clinical workflows, suppo...

Sponsored
https://kalkineauuknzusca.blob.core.windows.net/kalkineallsubdata/au/gallery/xlarge/shutterstock_2456036571_06_12_2026_03_34_17_959754.jpg

Kalkine ASX Update: What Is Supporting Momentum in Invex Therapeutics (ASX: IXC)?

June 12, 2026 03:32 AM AEST| By Aditi Sarkar

Invex Therapeutics Ltd (ASX:IXC) attracted investor attention on 12 June 2026 after its shares climbed 20.88% to AUD 0.11. The stock traded at AUD 0.11 throughout the session, with the day's open, high and low all recorded at the same level. The company currently …

 Diagnostics Drive Healthcare Stocks ASX 200 Focus

Diagnostics Drive Healthcare Stocks ASX 200 Focus

June 10, 2026 01:55 PM AEST| By Sam

Healthcare stocks are attracting attention as diagnostics, devices, product adoption, reimbursement settings and clinical evidence become key themes across the Australian healthcare sector.

 Biotech Commercial Proof Shapes ASX Healthcare ASX 200

Biotech Commercial Proof Shapes ASX Healthcare ASX 200

June 10, 2026 01:55 PM AEST| By Sam

ASX healthcare stocks are evaluated on commercial proof, revenue momentum, adoption, clinical evidence and operational execution as the sector moves from trial outcomes to validated market performance.

 ASX Healthcare Stocks ASX 200 Valuation Repair Shaping Sector Attention

ASX Healthcare Stocks ASX 200 Valuation Repair Shaping Sector Attention

June 10, 2026 01:54 PM AEST| By Sam

ASX healthcare stocks are assessed through valuation repair, revenue momentum, product adoption, clinical evidence, margin quality, and operational execution across CSL, ResMed, Cochlear, Pro Medicus, and Telix Pharmaceuticals.

Sponsored
https://kalkineauuknzusca.blob.core.windows.net/kalkineallsubdata/au/gallery/xlarge/Biotechnologyn_06_12_2026_02_10_17_466725.jpg

Kalkine Investor Brief: Neurizon's (ASX:NUZ) ALS Trial Hits Milestone

June 12, 2026 02:07 AM AEST| By Sonal Goyal

 Why Is Telix Pharmaceuticals Drawing Attention Within the ASX 200 Healthcare Space?

Why Is Telix Pharmaceuticals Drawing Attention Within the ASX 200 Healthcare Space?

June 10, 2026 10:04 AM AEST| By Sam

Telix Pharmaceuticals remains a healthcare stock to watch as clinical development, commercial growth and strategic partnerships continue driving attention.

 Is Pro Medicus Losing Its Premium Edge in a Fast-Changing Healthcare Market?

Is Pro Medicus Losing Its Premium Edge in a Fast-Changing Healthcare Market?

June 10, 2026 10:00 AM AEST| By Sam

Pro Medicus continues benefiting from healthcare digitisation, though competition and evolving technology trends are reshaping expectations for future growth.

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.